THAR
Price:
$2.47
Market Cap:
$86.56M
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed...[Read more]
Industry
Biotechnology
IPO Date
2022-01-12
Stock Exchange
NASDAQ
Ticker
THAR
According to Tharimmune, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 84.57M. This represents a change of 5.66% compared to the average of 1.47M of the last 4 quarters.
The mean historical Enterprise Value of Tharimmune, Inc. over the last ten years is 17.11M. The current 84.57M Enterprise Value has changed 49.33% with respect to the historical average. Over the past ten years (40 quarters), THAR's Enterprise Value was at its highest in in the December 2021 quarter at 41.71M. The Enterprise Value was at its lowest in in the December 2023 quarter at -4955944.20.
Average
17.11M
Median
17.91M
Minimum
-10270450.44
Maximum
41.71M
Discovering the peaks and valleys of Tharimmune, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 389.28%
Maximum Annual Enterprise Value = 41.71M
Minimum Annual Increase = -105.03%
Minimum Annual Enterprise Value = -10270450.44
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | -927892.30 | -90.97% |
| 2023 | -10270450.44 | 389.28% |
| 2022 | -2099113.96 | -105.03% |
| 2021 | 41.71M | 11.27% |
| 2020 | 37.49M | 2.00% |
The current Enterprise Value of Tharimmune, Inc. (THAR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4432485.57
5-year avg
13.18M
10-year avg
17.11M
Tharimmune, Inc.’s Enterprise Value is greater than BioLineRx Ltd. (19.48M), greater than GeoVax Labs, Inc. (4.72M), greater than Adlai Nortye Ltd. (3.81M), greater than Lunai Bioworks Inc. (33.22M), greater than SeaStar Medical Holding Corporation (-3752301.00), less than Adaptimmune Therapeutics plc (97.78M), greater than Ainos, Inc. (21.90M), greater than Apollomics, Inc. (7.47M), greater than Aditxt, Inc. (5.43M), greater than Moleculin Biotech, Inc. (3.01M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 19.48M | $14.17M | |
| 4.72M | $9.73M | |
| 3.81M | $37.48M | |
| 33.22M | $23.14M | |
| -3752301.00 | $10.01M | |
| 97.78M | $75.16M | |
| 21.90M | $12.03M | |
| 7.47M | $16.27M | |
| 5.43M | $62.61K | |
| 3.01M | $9.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tharimmune, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tharimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tharimmune, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Tharimmune, Inc. (THAR)?
What is the 3-year average Enterprise Value for Tharimmune, Inc. (THAR)?
What is the 5-year average Enterprise Value for Tharimmune, Inc. (THAR)?
How does the current Enterprise Value for Tharimmune, Inc. (THAR) compare to its historical average?